Singapore, Singapore · Founded 2022 · Privately Held (backing)
Developer of antibody-drug conjugate therapies designed for treating cancer. Axcynsis Therapeutics is based in Singapore, Singapore and was founded in 2022. Its last known valuation is $36.1 million. It has raised $21 million.
Last price · $/share
—
Implied valuation
$36.1M
Total raised
$21.0M
Last round
—
Cap table — not yet on record
Axcynsis Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axcynsis Therapeutics with a free account
·Watch Axcynsis Therapeutics: the Monday email on marks, rounds and moves
